| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/16/2013 | CN102875477A Phenyl piperazinepyridazinone and preparation method as well as application thereof |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102872445A Traditional Chinese medicine for treating prostatitis |
| 01/16/2013 | CN102872437A Special-disease calculus-removing decoction for treating renal calculus |
| 01/16/2013 | CN102872430A Tablets for warmly invigorating spleen yang |
| 01/16/2013 | CN102872416A Traditional Chinese medicine sitting lotion for treating chronic prostatitis |
| 01/16/2013 | CN102872415A Traditional Chinese medicine enema for treating chronic prostatitis |
| 01/16/2013 | CN102872406A Stone-eliminating tea for rapidly expelling stones in liver, gallbladder, kidney and conduit lumen |
| 01/16/2013 | CN102872397A Traditional Chinese medicine composition for treating chronic cystitis |
| 01/16/2013 | CN102872366A Traditional Chinese medicine for treating prostatic hyperplasia |
| 01/16/2013 | CN102872339A Traditional Chinese medicine enema for treating radiation cystitis |
| 01/16/2013 | CN102872338A Traditional Chinese medicine preparation for treating chronic prostatitis |
| 01/16/2013 | CN102872334A Application of medicinal composition for treating diabetes mellitus |
| 01/16/2013 | CN102872313A Traditional Chinese medicine qi-tonifying and kidney-nourishing decoction for treating henoch-schonlein purpura nephritis |
| 01/16/2013 | CN102872298A Decoction medicament for treating kidney and spleen deficiency type proteinuria |
| 01/16/2013 | CN102872297A Tablets for tonifying kidney and replenishing essence |
| 01/16/2013 | CN102872280A Traditional Chinese medicine preparation for treating calculus in urinary system |
| 01/16/2013 | CN102872279A Tablets for clearing away lower energizer and dampness-heat |
| 01/16/2013 | CN102872239A Qi-tonifying and yang-raising tablets |
| 01/16/2013 | CN102872237A Skunk bugbane spleen-qi raising tablet |
| 01/16/2013 | CN102872229A Medicine for treating kidney stones |
| 01/16/2013 | CN102872223A Health protection medicine for enriching blood and prolonging life |
| 01/16/2013 | CN102872153A Application of Houttuynoid E in medicament for preventing and treating renal insufficiency |
| 01/16/2013 | CN102872150A Application of Houttuynoid B in medicament for treating prostatic cancer |
| 01/16/2013 | CN102872147A Application of Houttuynoid C in drugs for preventing and treating renal insufficiency |
| 01/16/2013 | CN102872140A Application of Houttuynoid C in drug for treating acute renal failure |
| 01/16/2013 | CN102872130A Application of Houttuynoid D in drug for preventing or treating renal fibrosis |
| 01/16/2013 | CN102872123A Application of Houttuynoid C in medicament for treating bladder cancer |
| 01/16/2013 | CN102872115A Application of Houttuynoid A in medicament for treating acute renal failure |
| 01/16/2013 | CN102872112A Application of Houttuynoid A in medicament for treating bladder cancer |
| 01/16/2013 | CN102872109A Application of Houttuynoid A in medicament for treating prostate cancer |
| 01/16/2013 | CN102872098A Application of Houttuynoid A in medicine for preventing and treating renal insufficiency |
| 01/16/2013 | CN102872097A Application of Houttuynoid D in medicine for treating acute renal failure |
| 01/16/2013 | CN102872094A Application of Houttuynoid B in medicine for treating acute renal failure |
| 01/16/2013 | CN102872083A Application of Houttuynoid B in medicines for treating or preventing renal fibrosis |
| 01/16/2013 | CN102872072A Application of Houttuynoid B to preparing drugs for treating kidney cancer |
| 01/16/2013 | CN102872070A Application of Houttuynoid C to preparing drugs for treating prostate cancer |
| 01/16/2013 | CN102872042A Application of Gypensapogenin B in medicaments for treating or preventing renal fibrosis |
| 01/16/2013 | CN102872041A Application of Gypensapogenin A in medicaments for preventing and treating renal insufficiency |
| 01/16/2013 | CN102872033A Application of Gypensapogenin A in medicaments for treating or preventing chronic heart failure renal fibrosis |
| 01/16/2013 | CN102872006A Applications of tagitinin a and derivatives thereof in treatment of metabolic diseases |
| 01/16/2013 | CN101869633B Enteric-coated medicament combination containing epigallocatechin gallate |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/10/2013 | WO2013006129A1 Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients |
| 01/10/2013 | WO2013006050A1 Peptides inducing or enhancing an immune response against prostate-specific membrane protein (PSMA) |
| 01/10/2013 | WO2013005216A1 Compositions and methods for treatment of renal ischemia-reperfusion injury |
| 01/10/2013 | WO2013004776A1 Supply of substances upstream of the haemodialysis membrane, e.g. of acetylcysteine, in dialysis methods for removing protein-bonded toxins from the blood |
| 01/10/2013 | WO2013004436A1 Compositions containing broccoli seeds for treating or preventing prostate cancer |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012548 Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compounds |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012499 Trpv4 antagonists |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012496 Benzazepine compound |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130011498 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |
| 01/10/2013 | US20130011444 Compositions and methods for overcoming resistance to tramadol |
| 01/10/2013 | US20130011379 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 01/10/2013 | CA2839972A1 Compositions containing broccoli seeds extract for treating or preventing prostate cancer |
| 01/09/2013 | EP2543729A1 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor |
| 01/09/2013 | EP2543369A2 Solution for peritoneal dialysis |
| 01/09/2013 | EP2542244A1 Use of meloxicam for the long-term treatment of kidney disorders in cats |
| 01/09/2013 | CN1994337B Total flavone extract of maniod eibish, preparation and application thereof |
| 01/09/2013 | CN102869669A Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/09/2013 | CN102869665A Benzazepine compound |
| 01/09/2013 | CN102869656A Tetrahydrobenzothiophene compound |
| 01/09/2013 | CN102864124A Renal-source stem/progenitor cell for expressing nestin |
| 01/09/2013 | CN102864088A Genetically engineering lactobacillus and application thereof |
| 01/09/2013 | CN102863538A Fused polypeptide mutant containing protein transduction domain and preparation method thereof |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102861376A Medication therapy system for curing nephropathy in rehabilitation mode through targeted guiding of Chinese herbal medicinal ingredients into renal region |
| 01/09/2013 | CN102861343A Application of secretory type Klotho in preparing medicine for treating chronic renal failure |
| 01/09/2013 | CN102861314A Medicine for treating nephropathy and preparation method thereof |
| 01/09/2013 | CN102861302A Traditional Chinese preparation for treating benign prostatic hyperplasia and preparation method for traditional Chinese preparation |
| 01/09/2013 | CN102861288A Traditional Chinese medicine composite for treating kidney stone |
| 01/09/2013 | CN102861251A Chinese medicine for treating liver and kidney yin deficiency renal calculus by using lygodium |
| 01/09/2013 | CN102861230A Application of Chinese medicine composition in preparing medicines for treating organ fibrosis |
| 01/09/2013 | CN102861200A Application of gynecological ten-medicament preparation to preparation of medicament for treating prostatic disorders |
| 01/09/2013 | CN102861192A Medicine composition for chronic renal failure and peritoneal fibrosis |
| 01/09/2013 | CN102861170A Traditional Chinese medicine composition for treating frequent micturition |
| 01/09/2013 | CN102861163A Compound centella asiatica enema and preparation method thereof |
| 01/09/2013 | CN102861156A Traditional Chinese medicine for dampness and heat accumulation type kidney stone |
| 01/09/2013 | CN102861134A Six-ingredient litholytic powder |
| 01/09/2013 | CN102861097A Application of Houttuynoid E in medicine for treating bladder cancer |
| 01/09/2013 | CN102861095A Application of Houttuynoid E in medicine for treating acute renal failure |
| 01/09/2013 | CN102861088A Application of Houttuynoid D in medicine for preventing and treating renal insufficiency |
| 01/09/2013 | CN102861085A Application of Houttuynoid E in medicine for treating or preventing renal fibrosis |
| 01/09/2013 | CN102861082A Application of Houttuynoid B in medicine for preventing and treating renal insufficiency |
| 01/09/2013 | CN102861072A Application of Houttuynoid A in medicine for treating or preventing renal fibrosis |
| 01/09/2013 | CN102861063A Application of Houttuynoid C in medicine for treating or preventing renal fibrosis |
| 01/09/2013 | CN102861029A Application of Gypensapogenin B in medicine for treating hemorrhagic fever with renal syndrome |